Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
ORGN reported a Q2 loss of $0.14 per share, missing expectations. Sales of $7.03 million fell short of the $7.78 million forecast. Secured a 2-year MOU for PET closures, anticipated $100 million revenue. Analyst Steve Byrne upgraded ORGN to Buy; target raised to $3.00. Potential for profitability by 2026 due to new contracts and technology.
- ORGN reported a Q2 loss of $0.14 per share, missing expectations.
- Sales of $7.03 million fell short of the $7.78 million forecast.
- Secured a 2-year MOU for PET closures, anticipated $100 million revenue.
- Analyst Steve Byrne upgraded ORGN to Buy; target raised to $3.00.
- Potential for profitability by 2026 due to new contracts and technology.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.